<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Amendment in the notification no. 514/2017/9(120)/XXVII(8)/2017 dated 29th June, 2017</title>
    <link>https://www.taxtmi.com/notifications?id=145838</link>
    <description>Uttarakhand GST rate notification amends the existing schedule of goods under the State GST framework by inserting Trastuzumab Deruxtecan, Osimertinib and Durvalumab in Schedule I at 2.5%, adding extruded or expanded savoury or salted products in Schedule II at 6%, and revising Schedule III and IV entries for snack pellets and seats. The amendment is stated to be deemed effective from 10 October 2024.</description>
    <language>en-us</language>
    <pubDate>Fri, 09 May 2025 00:00:00 +0530</pubDate>
    <lastBuildDate>Tue, 26 May 2026 15:02:54 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=903882" rel="self" type="application/rss+xml"/>
    <item>
      <title>Amendment in the notification no. 514/2017/9(120)/XXVII(8)/2017 dated 29th June, 2017</title>
      <link>https://www.taxtmi.com/notifications?id=145838</link>
      <description>Uttarakhand GST rate notification amends the existing schedule of goods under the State GST framework by inserting Trastuzumab Deruxtecan, Osimertinib and Durvalumab in Schedule I at 2.5%, adding extruded or expanded savoury or salted products in Schedule II at 6%, and revising Schedule III and IV entries for snack pellets and seats. The amendment is stated to be deemed effective from 10 October 2024.</description>
      <category>Notifications</category>
      <law>GST - States</law>
      <pubDate>Fri, 09 May 2025 00:00:00 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/notifications?id=145838</guid>
    </item>
  </channel>
</rss>